Press room
  • Products
  • Science
  • About
  • Investor Relations
  • Products
    • Animal HealthNutraceuticalsWebinars
  • Science
    • Our SciencePatentsScientific Reports
  • About
    • About AxichemMissionVisionJoin UsEco-friendlyHistoryBusiness model
  • Investor Relations
    • Commissioned ResearchCompany descriptionCorporate GovernanceFinancial CalendarFinancial ReportsGeneral Meetings ArchiveInvestor EnquiriesInvestor structurePress ReleasesProspectus ArchiveAnnual General Meeting 2026
axichem.se Press releases
Inbjudan att teckna aktier i aXichem AB
Back
October 14, 2009
Inbjudan att teckna aktier i aXichem AB
Back

  • Härmed inbjuds allmänheten att teckna aktier i aXichem AB
  • 4,50 SEK aktie
Back
Further reading
September 11, 2026
aXichem enters into agreements on non-compensated subscription undertakings totaling approximately SEK 2.6 million regarding ongoing redemption of warrants of series TO2A
September 11, 2026
aXichem ingår avtal om vederlagsfria teckningsåtaganden om totalt cirka 2,6 MSEK avseende pågående inlösen av teckningsoptioner av serie TO2A
September 08, 2026
aXichem notes growing commercial adoption in Brazil for aXiphen[®] ruminant as Garra Nutrição increases volume to four tonnes
Our Brands
aXiphen
Animal Health - read more
aXivite
Nutraceuticals and life-science - read more
back to top
 
Södergatan 26
211 34 Malmö
SWEDEN
+46 40 12 13 55

 
About
Science and R&D
Products
Investor Relations
Press Room
Join Us
Contact
Sitemap

© aXichem AB 2024